（厚生労働省� �令和４年度診� ��報酬改定　疑 義解釈資料の� �付について（� ��の14）.pdf

The Ministry of Health, Labour and Welfare's Insurance Bureau, Medical Affairs Division, has issued a notice regarding the interpretation of certain medical treatment fees. The notice includes answers to several questions, including:

1. Regarding the "Medical Office Work Support System Addition" (zone number "A207-2"), it is acceptable to include periods of service at other medical institutions when calculating the 3-year service period.
2. For the "Report Management System Addition" (zone number "A234-5"), it is possible to add points even if the patient's hospitalization fee includes the cost of imaging or pathological diagnosis.
3. The term "anti-cancer drug" in the "Outpatient Tumor Chemotherapy Treatment Fee" (zone number "B001-2-12") refers to drugs classified as anti-tumor agents.
4. The "Biosimilar Introduction Initial Addition" (zone number "B001-2-12") can be added even if the drug used is not an anti-cancer drug.
5. The "Mental Health Liaison Guidance Fee (I)" (zone number "B005-12") requires a doctor to have received training in suicide prevention, which includes training provided by the Ministry of Health, Labour and Welfare and other specified organizations.
6. For the "Lower Limb Wound Treatment" (zone number "J000-2"), a shallow ulcer on the toe should be calculated as "135 points for a shallow ulcer on the foot (excluding the heel)".
7. For the "Lower Limb Wound Treatment" (zone number "J000-2"), the term "foot" refers to the area from the ankle joint to the toes (excluding the toes and heel).